Correlation Between SAB Biotherapeutics and Oncorus
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Oncorus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Oncorus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Oncorus, you can compare the effects of market volatilities on SAB Biotherapeutics and Oncorus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Oncorus. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Oncorus.
Diversification Opportunities for SAB Biotherapeutics and Oncorus
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between SAB and Oncorus is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Oncorus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncorus and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Oncorus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncorus has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Oncorus go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Oncorus
Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 0.68 times more return on investment than Oncorus. However, SAB Biotherapeutics is 1.47 times less risky than Oncorus. It trades about 0.0 of its potential returns per unit of risk. Oncorus is currently generating about -0.09 per unit of risk. If you would invest 1,000.00 in SAB Biotherapeutics on September 3, 2024 and sell it today you would lose (708.00) from holding SAB Biotherapeutics or give up 70.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 26.67% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Oncorus
Performance |
| Timeline |
| SAB Biotherapeutics |
| Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
SAB Biotherapeutics and Oncorus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Oncorus
The main advantage of trading using opposite SAB Biotherapeutics and Oncorus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Oncorus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncorus will offset losses from the drop in Oncorus' long position.| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
| Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |